KLONA BIOTECH
LIVE

Serial Number

99677708

Owner

Klona Biotech Inc.

Attorney

Connie L. Ellerbach

Filing Date

Mar 2, 2026

Add to watchlist:

No watchlists yet
View on USPTO

KLONA BIOTECH Trademark

Serial Number: 99677708

KLONA BIOTECH is a trademark filed by Klona Biotech Inc. on March 2, 2026. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Klona Biotech Inc.

251 Little Falls Drive
New Castle County, DE 19808

Entity Type: 03

Trademark Details

Filing Date

March 2, 2026

Registration Date

Not Registered

Goods & Services

Three-dimensional (3D) bioprinters for medical use; medical devices for printing biological tissues and cellular structures; biofabrication apparatus for creating living tissues for medical purposes; medical instruments for dispensing and depositing bioinks and biomaterials; printer heads and cartridges specially adapted for medical bioprinters; sterile printing chambers for medical bioprinting; tissue printing machines for medical applications; structural parts and fittings for the aforesaid medical apparatus

Downloadable software for controlling and operating three-dimensional (3D) bioprinters and biofabrication systems; downloadable software for designing and modeling biological structures for printing; downloadable software for processing and preparing biofabrication print files; downloadable software for monitoring and controlling biofabrication processes; downloadable software platforms for managing biological printing workflows; recorded operating software for bioprinting apparatus

Scientific research and development in the field of three-dimensional (3D) bioprinting and biofabrication; research and design of bioinks and biomaterials; product development in the field of tissue engineering and regenerative medicine; laboratory research services relating to engineered tissues and biological structures; design and testing of bioprinting processes and materials; biomedical research services; engineering and technical consulting services in the field of biological printing systems; development of custom biofabrication protocols and printing parameters for others

Bioinks comprised primarily of biological materials for medical use; biological preparations for tissue engineering for medical purposes; engineered biological tissues for regenerative medicine; living tissue constructs for medical use; implantable biological scaffolds for medical use; biomaterial matrices for medical use for tissue repair and regeneration; sterile biofabricated tissues for surgical implantation; regenerative medicine products, namely, engineered tissue grafts

Custom manufacturing of biological tissues and tissue constructs for others using three-dimensional (3D) bioprinting; contract bioprinting services for the production of biological materials and engineered tissues for others; custom fabrication of biomaterial scaffolds for third parties; additive manufacturing services in the field of biofabrication; custom manufacture of hydrogel and polymer biological structures for research and medical applications; bioprinting services, namely, fabrication of biological constructs to order for others

Biological and chemical compositions for use in scientific and laboratory research; polymer-based and hydrogel-based compositions for use in three-dimensional (3D) bioprinting for scientific use; unprocessed bioinks comprised of natural and synthetic polymers for scientific and research use; chemical reagents for use in tissue engineering and regenerative medicine research; cell culture media and cell growth supplements for laboratory use; scaffold materials in the nature of chemical preparations for use in biofabrication and tissue engineering; extracellular matrix (ECM) compositions for scientific and research use; collagen and gelatin-based biomaterials for scientific purposes; chemical substrates and support materials for use in additive manufacturing of biological structures

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 6, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jul 6, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jul 6, 2026 CNRT
ASSIGNED TO EXAMINER
Jun 29, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 28, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Mar 2, 2026 MAFR
NEW APPLICATION ENTERED
Mar 2, 2026 NWAP